oncology insights Decoding Cancer: How Genetic and Genomic Testing Advance Treatment December 13, 2024 Scientists have made remarkable progress in understanding the thousands of genes inside our...

Notice of Privacy Practices To allow a family member or agent to contact Prime on your behalf, please print, complete and return the release form below: Authorization for Release of Information |...

Perspectives Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage Approximately 83,000 new bladder cancer cases are diagnosed in the U.S. in each...

publications Radiopharmaceutical discovery and use is gaining momentum March 14, 2025 Author: Abby Kim, PharmD, BCOP Introducing Abby Kim, PharmD, BCOP Abby Kim, a Board-Certified Oncology...

Commercial formularies Breadcrumb Home Other Navigation Pharmacy + Providers Commercial Formularies PrimeChoice Accord Formulary PrimeChoice Accord Formulary Updates NetResults A-Series...

Oncology Insights: Transformative treatment for small cell lung cancer After decades of research, a new treatment is emerging for this aggressive form of lung cancer. By: Simone Ndujiuba, PharmD,...

Diversity, equity and inclusion Our commitment to diversity, equity and inclusion (DEI) is rooted in our purpose and dedication to serving others. Breadcrumb Home Who we are Diversity, equity and...

Effective: January 2021 Terms of use IF YOU ARE EXPERIENCING A MEDICAL EMERGENCY, DIAL 911 AND/OR SEEK IMMEDIATE ATTENTION FROM A HEALTH CARE PROVIDER. THIS WEBSITE DOES NOT PROVIDE MEDICAL...

Breadcrumb Prime Therapeutics Newsroom Custom Content Publications Drug Approvals: October 2024 PUBLICATIONS Drug Approvals: October 2024 This monthly update of United States (U.S.) Food and Drug...

publications Drug Approvals: March 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches March 26, 2025 Specialty New drugs March...

Identifying the associated medical cost savings with improving medication adherence study earns organization’s platinum award.

Pharmacy Times

Fall 2024 edition provides insights into groundbreaking specialty solutions for managed care

publications Drug Approvals: April 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches April 29, 2025 Specialty New drugs March...

Check inquiry Breadcrumb Home Other Navigation Pharmacy + Providers Check inquiry This form is specifically used to request a check reissue. For remittance requests, please use the following link:...

Drug Approvals Monthly Update: October 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

Cover image for The state of value-based contracting 2.0 An update on Medicaid payment models and opportunities Prime Therapeutics Value-based contracts (VBCs) are performance-based reimbursement...

Event features Prime's Health Outcomes team

Disclaimer THIS WEBSITE IS AN OPTIONAL RESOURCE FOR HEALTH CARE PROVIDERS ONLY. IF YOU ARE NOT A HEALTH CARE PROVIDER OR AUTHORIZED PROFESSIONAL USER, YOU ARE NOT TO USE THIS SITE AT ALL AND ARE...

Prime Perspective Breadcrumb Home Other Navigation Pharmacy + Providers Prime Perspective Pharmacy newsletter from Prime Therapeutics that provides information and updates about Prime services....

publications Fall 2024 Prime Therapeutics Report October 21, 2024 Debuting a new name and design, the 41st edition of our managed care report still offers the same in-depth industry articles on...

cover image for Drug Approvals: December 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo...

Cover image for Drug approvals Critical updates in an ever-changing environment  Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo Prime Therapeutics...

Becker’s Payer Issues

Cover image for Summer 2023 Prime Therapeutics Report Gene Therapy Update Prime Therapeutics https://issuu.com/primetherapeutics/docs/2023_pt_summer_report_pdf?fr=xKAE9_zU1NQ Explore the report ...

The American Journal of Managed Care (AJMC): At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection,...

publications Summer 2024 Prime Therapeutics Report June 11, 2024 The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. This issue’s cover story...

Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage

cover image for Drug Approvals: November 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-november-2024 Prime Therapeutics’ Drug Approvals provides an...

Cover image for Drug Approvals: March 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

cover image for Drug Approvals: July 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

Drug Approvals Quarterly Update: October 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process. Prime...

Cover image for Drug Approvals: February 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

cover image Drug Approvals: April 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches Prime Therapeutics...

cover image for 2024 summer report Pulmonary arterial hypertension: Exciting new approval and payer impact Prime Therapeutics /2024-summer-prime-therapeutics-report The Prime Therapeutics Report...

Jessica Johnson, clinical consultant at Prime's Special Investigations Unit, shares tips to stay safe when using online pharmacies

Corporate Equality Index is a prominent benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality

Hear the first part of a two-part preview of the research the Prime Therapeutics health outcomes team will present at the annual managed care pharmacy event

Our journey to reimagine pharmacy We are fueled by the desire to deliver an intuitive, meaningful, affordable experience that customers and members appreciate. By combining our innovation and...

Discover the latest trends and emerging strategies to manage rising medical benefit specialty drug spend.

Recognition benchmarks disability workplace inclusion against other companies

Perspectives Expert Clinical Network Insights: June 2024 A look into our Expert Clinical Network (ECN) — part of Prime/MRx’s value-based approach to medical and pharmacy benefit management that...

Jared Scripture, health outcomes scientist, shares more about the study “Leveraging Publicly Available SDOH Measures to Segment Members and Quantify Differences in Diabetic Medication Adherence: A...

Jessica Johnson, clinical consultant at Prime, shares some tips to stay safe

Specialty Pharmacy Continuum

Researchers share insights on accelerated approvals, health equity in food allergies and legislative impacts on sight of service

AMCP Nexus offers opportunity to nurture next generation of managed care leaders

Drug pricing information Breadcrumb Home Other Navigation Pharmacy + Providers Drug Pricing Information Georgia NADAC Reports 2024 Jan-Apr 2024 Document #1 | Document #2 (last posted June 14, 2024)...

publications Quarterly Drug Approvals: January 2025 This report provides an overview of new drugs and indications approved in 2024 January 31, 2025 Specialty drug approvals Specialty drug...

publications Quarterly Drug Approvals: April 2025 This report provides an overview of new drugs and indications approved in 2025 April 24, 2025 Specialty drug approvals Specialty drug approvals -...

publications Quarterly Drug Approvals: October 2024 This report provides an overview of new drugs and indications approved in 2024 October 31, 2024 Specialty drug approvals Specialty drug...

Connect care for your members with cancer IntegratedRx® – Oncology puts everyone on the same team and gives members a central location for their cancer medicines. Breadcrumb Home Our solutions...

Connect care for your members with cystic fibrosis IntegratedRx – Cystic Fibrosis helps deliver an integrated care experience for members and their providers. Breadcrumb Home Our solutions...

Provide a uniquely integrated experience More connected care helps curb costs and improve the experience for your members with cancer and cystic fibrosis. Breadcrumb Home Our solutions Specialty...

Help your members living with cystic fibrosis We support members navigating their cystic fibrosis (CF) with a holistic, customized approach to care. Breadcrumb Home Our solutions Condition...

Support your members with asthma and COPD Our solutions help your members with asthma and chronic obstructive pulmonary disease (COPD) stay healthy. Breadcrumb Home Our solutions Condition...

Members on cancer care journey laud Prime’s integrated clinic-to-pharmacy experience

Prime leaders discuss rebates, reporting and other state issues at hybrid conference in Chicago.

Care for your members living with cancer Our deep expertise and holistic view of care help your members manage their oncology drugs and simplify their experience. Breadcrumb Home Our solutions...

Experts in Medicaid pharmacy delivery engage in timely discussion of states’ access and cost challenges and offer Prime’s solutions to fill resource gaps and improve health outcomes for people...